Clinical research

Long-term comparison of everolimus-eluting and biolimus-eluting stents

EuroIntervention 2013;9:336-344 published online ahead of print March 2013. DOI: 10.4244/EIJV9I3A55

Serban Puricel
Serban Puricel, MD; Markus Oberhänsli, MD; Patricia Guntern, SN; Sonja Lehmann, SN; Jean-Jacques Goy, MD; Diego Arroyo, MD; Hélène Villeneuve, SN; Gérard Baeriswyl, MD; Jean-Christophe Stauffer, MD; Mario Togni, MD; Stéphane Cook*, MD
Department of Cardiology, University Hospital, Fribourg, Switzerland

Aims: Second-generation everolimus-eluting stents (EES) are safer and more efficient than first-generation paclitaxel-eluting stents (PES). Thir

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

clinical researchpercutaneous coronary interventionstent thrombosis
Read next article
Full conversion from transfemoral to transradial approach for percutaneous coronary interventions results in a similar success rate and a rapid reduction of in-hospital cardiac and vascular major events

Latest news